Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Highlights ► Risk behaviour over time in the first HIV efficacy trial in South Africa is reported. ► No evidence of sexual risk compensation is observed. ► Good uptake of medical circumcision among male participants.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2013-04, Vol.31 (16), p.2089-2096
Hauptverfasser: Gray, G.E, Metch, B, Churchyard, G, Mlisana, K, Nchabeleng, M, Allen, M, Moodie, Z, Kublin, J, Bekker, L.-G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► Risk behaviour over time in the first HIV efficacy trial in South Africa is reported. ► No evidence of sexual risk compensation is observed. ► Good uptake of medical circumcision among male participants.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.01.031